European Artificial Tear Market Hits $1,150.0 million in 2025 with 4.4% CAGR

European artificial tear market was valued at $1,150.0 million in 2025 and is growing at a CAGR of 4.4% during the forecast period (2026-2035). Recent European Commission approvals for new ophthalmic formulations are expediting market entry and expanding treatment options for patients with moderate to severe dry eye disease (DED). These regulatory developments are strengthening the availability of advanced therapies across Europe and selected MENA regions, thereby supporting overall market growth. For instance, in October 2024, Novaliq and Laboratoires Théa received European Commission approval for ciclosporin 0.1% eye drops solution, branded as Vevizye, for treating dry eye disease (DED). Laboratoires Théa will commercialize the product in Europe and select Middle Eastern and North African countries. Previously approved by the FDA as VEVYE, Vevizye targets moderate to severe DED in adults unresponsive to tear substitutes. Its efficacy was demonstrated in the ESSENCE-1 and ESSENCE-2 clinical trials, focusing on changes in total corneal fluorescein staining (tCFS) scores.

Browse the full report description of “European Artificial Tear Market Size, Share & Trends Analysis Report by Type (Cellulose-Derived Tears, Glycerin-Derived Tears, Oil-Based Emulsion Tears, and Polyethylene Glycol- & Propylene Glycol-Based Tears), By Application (Dry Type Treatment, Contact Lens Moisture, and Digital Eye Strain) By Delivery Method (Eyedrops and Ointments/Gel) By End-User (Retail Pharmacies (OTC), Online Pharmacies, Hospitals & Ophthalmic Clinics, and Other End User), Forecast Period (2026-2035)” of https://www.omrglobal.com/industry-reports/european-artificial-tears-market

Key Innovators Driving European Artificial Tear Transformation

The key players in the european artificial tear market include Alcon Inc., Allergan (AbbVie Inc.), Bausch & Lomb, Johnson & Johnson, Santen Pharmaceutical Co., Ltd., among others. These companies are driving innovation in digital health solutions such as telemedicine, electronic health records, remote patient monitoring, and AI-powered clinical tools, shaping the future of healthcare delivery globally.

• In June 2025, Bausch + Lomb presented findings at the European Dry Eye Congress (EuDEC) in Krakow, focusing on a survey about dry eye disease across Europe and the Middle East. Key survey results include that 58% of dry eye sufferers report frequent symptoms, yet only 20% are diagnosed. Moreover, 60% waited over four months before seeking help. One-third have suffered for over five years, with lifestyle impacts such as 17% avoiding night driving, 14.8% not using makeup, and 15.2% reducing air conditioning usage due to symptoms. Additionally, around 33% noted worsening symptoms in the past year, while a few reported improvement.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Application
  • By Delivery Method
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Alcon Inc., Allergan (AbbVie Inc.), Bausch & Lomb, Johnson & Johnson, Santen Pharmaceutical Co., Ltd., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

European Artificial Tear Market Report Segment

By Type

• Cellulose-Derived Tears
• Glycerin-Derived Tears
• Oil-Based Emulsion Tears
• Polyethylene Glycol- & Propylene Glycol-Based Tears

By Application

• Dry Type Treatment
• Contact Lens Moisture
• Digital Eye Strain

By Delivery Method

• Eyedrops
• Ointments/Gel

By End-Users

• Retail Pharmacies (OTC)
• Online Pharmacies
• Hospitals & Ophthalmic Clinics
• Others

European Artificial Tear Market Report Segment by Region

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-artificial-tears-market